California Institute for Regenerative Medicine (CIRM)
Overview
The California Institute for Regenerative Medicine (CIRM) is a state agency established by the people of California to accelerate stem cell, regenerative medicine, and gene therapy research. As part of its mission, CIRM advances transformative treatments for serious diseases while prioritizing equity and access for diverse communities across California and the world. Through its funding programs, CIRM drives innovation, supports the development of critical research infrastructure, and invests in training the next generation of scientists to lead the way in advancing regenerative medicine.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ReviR Therapeutics | Nov 2025 | Grant | Lead |
| Ray Therapeutics | Apr 2025 | Grant | Lead |
| Tenaya Therapeutics | Feb 2025 | Grant | - |
| Senti Biosciences | Jun 2024 | Grant | - |
| Ray Therapeutics | Nov 2023 | Grant | Lead |
Key People
Rehaan KHAN
Managing Director
Candy Sheehan
Partner Business Executive
Cynthia Kiefer
MAT Access Point GRANT Partner
Amy Maxwell
Vice Principal
Douglas Humphrey
Principal State Architect
GariRae Gray
Principal, DPM III
Kelly Custer
Vice Principal
Marjorie Swartz
Principal Consultant
Mary Cornelius
Principal (retired)
nancy lynne
Principal
Nelson Orellana
Principal Enterprise Applications Architect
Pamela D.
Principal Property Appraiser
Rick Babb
Principal
Rob Schmidt
Principal Technologist
Sajal Krishn
Sr. Principal Program Manager -Strategy And Consulting
Silva Saghbazarian
Principal Auditor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
